2-Aminopyridine derivatives as potential σ(2) receptor antagonists

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Oncology

Background:

• Sigma (σ) receptors, particularly σ(2), are of significant interest for cancer therapy and diagnosis.
• Current research is limited by a lack of high-affinity σ(2) antagonists.
• Previous work suggested modifying lipophilicity could yield potential σ(2) antagonists.

Purpose of the Study:

• To synthesize novel σ receptor ligands with antagonist properties at the σ(2) receptor.
• To explore the potential of 2-aminopyridine derivatives as σ receptor modulators.
• To investigate the impact of structural modifications on ligand affinity and activity.

Main Methods:

• Chemical synthesis involving the replacement of the tetralin nucleus in compound 4 with a 2-aminopyridine moiety.
• In vitro evaluation of ligand binding affinity for σ(1) and σ(2) receptors.
• Assessment of antiproliferative activity in various cancer and neuronal cell lines (HT-22, SK-N-SH, MCF-7wt, MCF-7σ(1)).
• Investigation of calcium (Ca(2+)) mobilization effects for key compounds.

Main Results:

• A series of novel 2-aminopyridine compounds were synthesized, exhibiting high affinity for both σ(1) and σ(2) receptors.
• These compounds demonstrated no antiproliferative activity across tested cell lines.
• Compounds 18 and 4 displayed opposing effects on Ca(2+) mobilization.
• The novel ligands function as σ(2) receptor antagonists and σ(1) receptor agonists.

Conclusions:

• The newly synthesized 2-aminopyridine derivatives represent valuable high-affinity σ receptor ligands.
• These compounds exhibit σ(2) antagonist and σ(1) agonist activity, serving as potential tools for σ receptor research.
• Despite lacking high σ(2)/σ(1) selectivity, these ligands offer advantages over existing low-affinity σ(2) antagonists.